SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-22-002736
Filing Date
2022-05-02
Accepted
2022-05-02 16:30:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 EIGER BIOPHARMACEUTICALS, INC. p22-1375sc13g.htm SC 13G 105761
  Complete submission text file 0000902664-22-002736.txt   107420
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

IRS No.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87931 | Film No.: 22882413
SIC: 2836 Biological Products, (No Diagnostic Substances)